Weight-loss drugs could be key in lowering US obesity rates – experts

Medications like Ozempic transformed' diabetes care because they improved health outcomes, say experts

Obesity rates have decreased slightly in the US and while it's too early to say whether the trend will hold and what's causing the change, experts believe weight-loss drugs could be playing a role in continuing to lower obesity and reduce related health risks.

These medications - Ozempic, Wegovy, Mounjaro and others - are called GLP-1 agonists, and they were originally developed to treat type 2 diabetes. But they also show great promise for treating obesity and other health conditions, like heart disease, kidney and liver issues, sleep apnea, asthma, Covid complications and cancer, among others.